NANJING,China- Triastek Inc rencently announced that their first 3D printing medicine “T19” was approved to conduct clinical trials by NMPA. It is the first known 3D printed drug product that has been known to obtain IND approved in China. Triastek Inc, established in July 2015, is a leading company in 3D printing of medicine,aslo a pioneer of new generation of digital pharmaceutical technology.As a technology driven company, Triastek has developed proprietary technologies that span the entir...